Maher Albitar, Chief Medical Officer at NEOGENOMICS INC (NEO), sold 120,150 shares at $8.21 ($988K) on 2016-09-12, disclosed to the SEC on 2016-09-13.
Open-market sale of $988k NEO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.31 | 9,075 | $75K | 7.6% |
| 2 | $8.31 | 9,075 | $75K | 7.6% |
| 3 | $8.21 | 51,000 | $419K | 42.4% |
| 4 | $8.21 | 51,000 | $419K | 42.4% |
| Total | $8.23 avg | 120,150 | $988K | 100% |
| Filing → |
| NEO | SELL | 2016-08-23 | $3.0M | — | Filing → |
| NEO | BUY | 2014-03-31 | $51K | — | Filing → |